This inventor holds 2 USPTO granted patents. Top assignees: Bcm Developement Inc., Bioxel Pharma Inc.. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2004
Title: Michel Pagé: Innovator in Cancer Therapy
Introduction
Michel Pagé is a notable inventor based in Québec, Canada. He has made significant contributions to the field of cancer therapy through his innovative work on carbohydrate derivatives of paclitaxel and docetaxel. With a total of 2 patents, his inventions focus on enhancing the solubility and efficacy of these important compounds.
Latest Patents
Michel Pagé's latest patents include "Carbohydrate derivatives of paclitaxel and docetaxel, method for producing same and uses thereof." This invention relates to new carbohydrate derivatives that exhibit increased solubility in water compared to the parent compounds, paclitaxel and docetaxel. These derivatives are produced from naturally occurring precursor molecules, which upon hydrolysis yield these natural precursors along with the original paclitaxel and docetaxel molecules. The invention also encompasses the composition and use of such derivatives for cancer therapy, as well as their potential applications in antifungal or antiviral therapy. Another significant patent is "Derivatives of paclitaxel, method for producing same and uses thereof," which focuses on new paclitaxel derivatives that maintain comparable cytotoxicity to the parent compound, along with their applications in drug targeting therapy.
Career Highlights
Throughout his career, Michel Pagé has worked with various companies, including Bcm Development Inc. and Bioxel Pharma Inc. His work has been instrumental in advancing the development of therapeutic agents aimed at treating cancer.
Collaborations
Michel has collaborated with notable individuals in his field, including Cyrille Bicamumpaka and Abdelilah Benosman. These collaborations have contributed to the success and impact of his inventions.
Conclusion
Michel Pagé is a distinguished inventor whose work in developing carbohydrate derivatives of paclitaxel and docetaxel has the potential to revolutionize cancer therapy. His innovative approach and dedication to research continue to make a significant impact in the medical field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile